NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $2.09 -0.02 (-0.95%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Cronos Group Stock (NASDAQ:CRON) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cronos Group alerts:Sign Up Key Stats Today's Range$2.09▼$2.1250-Day Range$2.08▼$2.3452-Week Range$1.72▼$3.14Volume458,924 shsAverage Volume1.93 million shsMarket Capitalization$799.00 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingSell Company OverviewCronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More… top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Cronos Group Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks37th Percentile Overall ScoreCRON MarketRank™: Cronos Group scored higher than 37% of companies evaluated by MarketBeat, and ranked 795th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingSell Consensus RatingCronos Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCronos Group has received no research coverage in the past 90 days.Read more about Cronos Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.05) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -13.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -13.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cronos Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.46% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in Cronos Group has recently decreased by 1.20%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.46% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in Cronos Group has recently decreased by 1.20%, indicating that investor sentiment is improving. News and Social Media2.7 / 5News Sentiment0.94 News SentimentCronos Group has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cronos Group this week, compared to 3 articles on an average week.Search InterestOnly 3 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat Follows5 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Stock News HeadlinesCronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024October 29 at 4:15 PM | globenewswire.comSpotlight On TSX Penny Stocks For October 2024October 22, 2024 | finance.yahoo.comtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.October 31, 2024 | Traders Agency (Ad)Cronos Group Inc. stock remains steady Wednesday, underperforms marketOctober 16, 2024 | marketwatch.comCronos Group’s Uncertain Path to Profitability Amid Regulatory Hurdles and Valuation PressuresOctober 15, 2024 | markets.businessinsider.comSpinach® Is the Number One Cannabis Brand in CanadaOctober 10, 2024 | globenewswire.comBeta Fiction Spain, Distributor of ‘Emmanuelle,' ‘We Live in Time,' Taps Director Arantxa Echevarría for ‘Dolores' (EXCLUSIVE)September 20, 2024 | msn.comCronos Group Inc. (CRON): A Bull Case TheorySeptember 18, 2024 | finance.yahoo.comSee More Headlines CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.09 on January 1st, 2024. Since then, CRON stock has increased by 0.0% and is now trading at $2.09. View the best growth stocks for 2024 here. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) announced its quarterly earnings data on Thursday, August, 8th. The company reported ($0.02) EPS for the quarter. The business earned $27.76 million during the quarter, compared to analysts' expectations of $25.85 million. Cronos Group had a negative trailing twelve-month return on equity of 2.06% and a negative net margin of 56.43%. Who are Cronos Group's major shareholders? Top institutional investors of Cronos Group include Intact Investment Management Inc. (0.10%) and International Assets Investment Management LLC (0.01%). View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/08/2024Today10/31/2024Next Earnings (Confirmed)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CRON CUSIPN/A CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees356Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.50 Low Stock Price Target$2.50 Potential Upside/Downside+43.5%Consensus RatingSell Rating Score (0-4)1.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,960,000.00 Net Margins-56.43% Pretax Margin-61.24% Return on Equity-2.06% Return on Assets-1.99% Debt Debt-to-Equity RatioN/A Current Ratio28.29 Quick Ratio27.41 Sales & Book Value Annual Sales$101.78 million Price / Sales7.85 Cash FlowN/A Price / Cash FlowN/A Book Value$2.87 per share Price / Book0.73Miscellaneous Outstanding Shares382,295,000Free Float355,917,000Market Cap$799.00 million OptionableOptionable Beta0.97 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:CRON) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.